| __timestamp | ACADIA Pharmaceuticals Inc. | Novavax, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 32748000 | 19928000 |
| Thursday, January 1, 2015 | 90804000 | 30842000 |
| Friday, January 1, 2016 | 186456000 | 46527000 |
| Sunday, January 1, 2017 | 255062000 | 34451000 |
| Monday, January 1, 2018 | 265758000 | 34409000 |
| Tuesday, January 1, 2019 | 325638000 | 34417000 |
| Wednesday, January 1, 2020 | 388661000 | 145290000 |
| Friday, January 1, 2021 | 396028000 | 298358000 |
| Saturday, January 1, 2022 | 369090000 | 488691000 |
| Sunday, January 1, 2023 | 402466000 | 468946000 |
Unleashing the power of data
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Over the past decade, ACADIA Pharmaceuticals Inc. and Novavax, Inc. have shown distinct approaches to handling these costs. From 2014 to 2023, ACADIA's SG&A expenses grew by approximately 1,130%, peaking in 2023. In contrast, Novavax's expenses surged by nearly 2,250% during the same period, with a significant spike in 2022. This suggests that while both companies have increased their spending, Novavax has experienced more volatility. The data highlights the importance of strategic cost management in the pharmaceutical industry, where efficient allocation of resources can be a key differentiator. As the industry evolves, monitoring these trends will be essential for investors and stakeholders alike.
Operational Costs Compared: SG&A Analysis of Novo Nordisk A/S and Novavax, Inc.
Gilead Sciences, Inc. vs Novavax, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Blueprint Medicines Corporation vs ACADIA Pharmaceuticals Inc.
Who Optimizes SG&A Costs Better? Grifols, S.A. or Novavax, Inc.
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs ACADIA Pharmaceuticals Inc. Trends and Insights
ADMA Biologics, Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and MorphoSys AG
Who Optimizes SG&A Costs Better? ACADIA Pharmaceuticals Inc. or MannKind Corporation
Cost Management Insights: SG&A Expenses for ACADIA Pharmaceuticals Inc. and Geron Corporation
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and BioCryst Pharmaceuticals, Inc.
ACADIA Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Novavax, Inc.